Pattern of immunoglobulin and T-cell receptor-δ/γ gene rearrangements in Iranian children with B-precursor acute lymphoblastic leukemia. 2014

Behzad Poopak, and Najmaldin Saki, and Ali Akbar Purfatholah, and Hossein Najmabadi, and Yosef Mortazavi, and Mohammad T Arzanian, and Gelareh Khosravipour, and Fariba Haghnejad, and Fatemeh Salari, and Mohammad Shahjahani

BACKGROUND Acute lymphoblastic leukemia (ALL) cells have unique rearranged immunoglobulin heavy chain (IgH), immunoglobulin light chain (IgK), and T-cell receptor (TCR) genes, which can be used as markers for clonality assay and evaluation of minimal residual disease. In this study, we have evaluated the pattern of IgH, IgK chains, and TCRG/D gene rearrangements in precursor-B ALL. METHODS In our prospective study, hyper-variable regions (CDRI and III) of IgH, TCRD (Vδ2-Dδ3 and Dδ2-Dδ3), TCRG (Vγ, VγI, and VγII), and IgK (Vκ-Kde) were studied in 126 cases with diagnosis of B-precursor ALL. RESULTS One hundred and fourteen (90.5%) out of 126 patients had clonal rearrangements of IgH using consensus primers for CDRI and/or CDRIII regions. Monoclonal, biclonal, and oligoclonal patterns were observed in 63 (57.8%), 38 (34.9%), and 6 (5.5%) patients with IgH (CDRIII) rearrangements, respectively. Clonal rearrangements of TCRG (Vγ) and VγI/II were present in 79.3 and 64.9% of patients, respectively, and only 5% of cases showed biclonal pattern. The VγII rearrangement was the most common (46.8%) type in TCRG. Vδ2-Dδ3 and Dδ2-Dδ3 partial gene rearrangements were observed in 47 (45.2%; n = 104) and 11 (16.6%; n = 66) patients, respectively. Biclonal/oligoclonal patterns were present in 13 (27.7%) and 2 (4.3%) cases with Vδ2-Dδ3 rearrangement, respectively. Only one patient had biclonal Dδ2-Dδ3 rearrangement. Clonal pattern of IgK-Kde was detected in 59 cases (67%; n = 88). CONCLUSIONS Our findings showed that clonal rearrangements of IgH and TCRD (Vδ2-Dδ3 and Dδ2-Dδ3) genes had similar patterns to other studies. Frequency of TCRG (VγI and VγII) and IgK rearrangements was found to be slightly higher than previous reports. Among the IgK rearrangements, VKI (25%) was the most common.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D007145 Immunoglobulin kappa-Chains One of the types of light chains of the immunoglobulins with a molecular weight of approximately 22 kDa. Ig kappa Chains,Immunoglobulins, kappa-Chain,kappa-Immunoglobulin Light Chains,Immunoglobulin kappa-Chain,kappa-Chain Immunoglobulins,kappa-Immunoglobulin Light Chain,kappa-Immunoglobulin Subgroup VK-12,kappa-Immunoglobulin Subgroup VK-21,Chains, Ig kappa,Immunoglobulin kappa Chain,Immunoglobulin kappa Chains,Immunoglobulins, kappa Chain,Light Chain, kappa-Immunoglobulin,Light Chains, kappa-Immunoglobulin,kappa Chain Immunoglobulins,kappa Chains, Ig,kappa Immunoglobulin Light Chain,kappa Immunoglobulin Light Chains,kappa Immunoglobulin Subgroup VK 12,kappa Immunoglobulin Subgroup VK 21,kappa-Chain, Immunoglobulin,kappa-Chains, Immunoglobulin
D007223 Infant A child between 1 and 23 months of age. Infants
D007492 Iran A country bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan. The capital is Tehran. Islamic Republic of Iran
D008297 Male Males
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Behzad Poopak, and Najmaldin Saki, and Ali Akbar Purfatholah, and Hossein Najmabadi, and Yosef Mortazavi, and Mohammad T Arzanian, and Gelareh Khosravipour, and Fariba Haghnejad, and Fatemeh Salari, and Mohammad Shahjahani
July 2000, Leukemia research,
Behzad Poopak, and Najmaldin Saki, and Ali Akbar Purfatholah, and Hossein Najmabadi, and Yosef Mortazavi, and Mohammad T Arzanian, and Gelareh Khosravipour, and Fariba Haghnejad, and Fatemeh Salari, and Mohammad Shahjahani
November 1988, Leukemia,
Behzad Poopak, and Najmaldin Saki, and Ali Akbar Purfatholah, and Hossein Najmabadi, and Yosef Mortazavi, and Mohammad T Arzanian, and Gelareh Khosravipour, and Fariba Haghnejad, and Fatemeh Salari, and Mohammad Shahjahani
March 1994, Acta paediatrica (Oslo, Norway : 1992),
Behzad Poopak, and Najmaldin Saki, and Ali Akbar Purfatholah, and Hossein Najmabadi, and Yosef Mortazavi, and Mohammad T Arzanian, and Gelareh Khosravipour, and Fariba Haghnejad, and Fatemeh Salari, and Mohammad Shahjahani
March 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Behzad Poopak, and Najmaldin Saki, and Ali Akbar Purfatholah, and Hossein Najmabadi, and Yosef Mortazavi, and Mohammad T Arzanian, and Gelareh Khosravipour, and Fariba Haghnejad, and Fatemeh Salari, and Mohammad Shahjahani
December 1988, The Journal of clinical investigation,
Behzad Poopak, and Najmaldin Saki, and Ali Akbar Purfatholah, and Hossein Najmabadi, and Yosef Mortazavi, and Mohammad T Arzanian, and Gelareh Khosravipour, and Fariba Haghnejad, and Fatemeh Salari, and Mohammad Shahjahani
July 2012, Leukemia & lymphoma,
Behzad Poopak, and Najmaldin Saki, and Ali Akbar Purfatholah, and Hossein Najmabadi, and Yosef Mortazavi, and Mohammad T Arzanian, and Gelareh Khosravipour, and Fariba Haghnejad, and Fatemeh Salari, and Mohammad Shahjahani
November 2008, Leukemia research,
Behzad Poopak, and Najmaldin Saki, and Ali Akbar Purfatholah, and Hossein Najmabadi, and Yosef Mortazavi, and Mohammad T Arzanian, and Gelareh Khosravipour, and Fariba Haghnejad, and Fatemeh Salari, and Mohammad Shahjahani
January 1990, Haematology and blood transfusion,
Behzad Poopak, and Najmaldin Saki, and Ali Akbar Purfatholah, and Hossein Najmabadi, and Yosef Mortazavi, and Mohammad T Arzanian, and Gelareh Khosravipour, and Fariba Haghnejad, and Fatemeh Salari, and Mohammad Shahjahani
February 1986, The Journal of experimental medicine,
Behzad Poopak, and Najmaldin Saki, and Ali Akbar Purfatholah, and Hossein Najmabadi, and Yosef Mortazavi, and Mohammad T Arzanian, and Gelareh Khosravipour, and Fariba Haghnejad, and Fatemeh Salari, and Mohammad Shahjahani
August 1992, Leukemia & lymphoma,
Copied contents to your clipboard!